Mach 1 Financial Group, LLC Bristol Myers Squibb CO Transaction History

Mach 1 Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $11 - $7,069	-92 Reduced 4.71%	1,860 $131,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $17,574 - $19,355	242 Added 14.15%	1,952 $149,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $922 - $1,105	-15 Reduced 0.87%	1,710 $124,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $92,511 - $107,847	1,725 New	1,725 $107,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $101,180 - $118,520	-1,710 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $21,481 - $24,159	362 Added 26.85%	1,710 $107,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $77,833 - $88,199	1,348 New	1,348 $83,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mach 1 Financial Group, LLC with notifications on news.